UroGen Pharma Future Growth

How is UroGen Pharma forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

Future Growth Score

5/6

Future Growth Score 5/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


56.1%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGM:URGN - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20252481953N/A2
12/31/2024132-55-11N/A4
12/31/202391-88-57N/A6
9/30/202262-109-86-86N/A
6/30/202258-114-87-87N/A
3/31/202254-113-82-81N/A
12/31/202148-111-86-85N/A
9/30/202140-113-87-86N/A
6/30/202132-111-94-93N/A
3/31/202119-117-99-98N/A
12/31/202012-128-107-106N/A
9/30/20204-137-112-111N/A
6/30/20200-130-99-98N/A
3/31/20200-121-89-89N/A
12/31/20190-105-71-71N/A
9/30/20190-90-55-55N/A
6/30/20190-88-52-52N/A
3/31/20191-84-46-46N/A
12/31/20181-76-38-37N/A
9/30/20181-62-34-33N/A
6/30/20189-42-22-21N/A
3/31/20189-30-17-16N/A
12/31/20178-21-10-10N/A
9/30/20172521010N/A
6/30/201718-734N/A
3/31/201718-434N/A
12/31/201618-434N/A
9/30/2016N/A-24-11-11N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: URGN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).

Earnings vs Market: URGN is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: URGN is expected to become profitable in the next 3 years.

Revenue vs Market: URGN's revenue (36% per year) is forecast to grow faster than the US market (7% per year).

High Growth Revenue: URGN's revenue (36% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if URGN's Return on Equity is forecast to be high in 3 years time


Discover growth companies